Big Pharma Threatens Europe Over Prices, Demands US Taxpayer Bailout
The pharmaceutical industry's ultimatum to Europe, demanding higher prices or no drugs, comes after striking 'deals' with the US government to lower costs domestically. This isn't innovation; it's extortion. For decades, US taxpayers have quietly funded pharmaceutical research, development, and ballooning profits through lax regulations and a refusal to negotiate drug prices. As of 2023, the
pharmaceutical and health products industry spent over $170 million on lobbying in the US, according to OpenSecrets, ensuring policies protect their profit margins. This threat to Europe is not about fair market competition; it's about exporting their price-gouging model globally, leveraging human desperation against national healthcare systems. One might wonder if their commitment to 'saving
lives' ends where their quarterly earnings reports begin.